金城医药

- 300233

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
金城医药(300233) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入93,169.66353,831.25256,875.27170,529.3382,952.65
营业收入93,169.66353,831.25256,875.27170,529.3382,952.65
二、营业总成本82,459.80329,366.78238,674.95157,048.3376,519.99
营业成本51,710.40199,112.71148,123.7496,972.1047,542.33
营业税金及附加1,041.893,615.522,809.721,830.52906.17
销售费用17,186.2268,064.7648,983.9831,556.5715,031.21
管理费用8,803.9439,075.0825,645.9518,425.309,393.52
财务费用-54.161,027.86929.25643.42796.52
研发费用3,771.5118,470.8512,182.327,620.422,850.24
资产减值损失----------
公允价值变动收益20.31-8.15-1.34-26.45-33.47
投资收益-16.4359.01-7.04-33.31-1.64
其中:对联营企业和合营企业的投资收益-31.57-73.05-24.38-15.69-24.58
汇兑收益----------
三、营业利润11,564.9622,584.9217,551.6313,417.426,874.76
加:营业外收入7.1998.4077.3572.6065.40
减:营业外支出16.67142.56-1.15-79.22-83.51
其中:非流动资产处置损失----------
四、利润总额11,555.4822,540.7517,630.1413,569.247,023.67
减:所得税费用2,639.583,209.652,964.642,491.981,535.71
五、净利润8,915.8919,331.1014,665.5011,077.265,487.97
归属于母公司所有者的净利润8,297.1317,470.9413,248.0410,170.945,015.47
少数股东损益618.761,860.161,417.47906.31472.50
六、每股收益
基本每股收益(元/股)0.22000.45000.34000.26000.1300
稀释每股收益(元/股)0.22000.45000.34000.26000.1300
七、其他综合收益--170.52705.67705.67551.12
八、综合收益总额8,915.8919,501.6215,371.1711,782.926,039.09
归属于母公司所有者的综合收益总额8,297.1317,641.4613,953.7010,876.615,566.59
归属于少数股东的综合收益总额618.761,860.161,417.47906.31472.50
下载全部历史数据到excel中 返回页顶